食道扁平上皮癌患者における早期腫瘍再発の予測

基本情報

NCT ID

NCT06476067

ステータス

募集中

試験のフェーズ

-

試験タイプ

観察

目標被験者数

150

治験依頼者名

City of Hope Medical Center

概要

The prognosis of patients with esophageal squamous cell carcinoma (ESCC) who develop post-operative early tumor recurrence is often relatively poor. Therefore, biomarker that can detect micro metastases before the start of treatment is required. Epigenomic alterations such as DNA methylation have attracted attention as promising biomarkers. The investigators aim to predict early recurrence based on whole genome DNA methylation analysis of esophageal cancer.

対象疾患

介入

依頼者（Sponsor）

実施施設 (2)